↓ Skip to main content

Efficacy and Safety Limitations of Attention-Deficit Hyperactivity Disorder Pharmacotherapy in Children and Adults

Overview of attention for article published in CNS Drugs, August 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (84th percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

patent
2 patents
wikipedia
11 Wikipedia pages

Citations

dimensions_citation
129 Dimensions

Readers on

mendeley
297 Mendeley
citeulike
2 CiteULike
Title
Efficacy and Safety Limitations of Attention-Deficit Hyperactivity Disorder Pharmacotherapy in Children and Adults
Published in
CNS Drugs, August 2012
DOI 10.2165/00023210-200923000-00004
Pubmed ID
Authors

Sharon B. Wigal

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 297 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 5 2%
Brazil 2 <1%
India 2 <1%
Spain 2 <1%
United Kingdom 2 <1%
Sweden 1 <1%
Israel 1 <1%
Norway 1 <1%
Canada 1 <1%
Other 0 0%
Unknown 280 94%

Demographic breakdown

Readers by professional status Count As %
Student > Master 49 16%
Researcher 35 12%
Student > Bachelor 34 11%
Student > Ph. D. Student 29 10%
Student > Doctoral Student 26 9%
Other 69 23%
Unknown 55 19%
Readers by discipline Count As %
Medicine and Dentistry 91 31%
Psychology 57 19%
Neuroscience 15 5%
Nursing and Health Professions 13 4%
Social Sciences 9 3%
Other 43 14%
Unknown 69 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 May 2023.
All research outputs
#3,270,088
of 22,774,233 outputs
Outputs from CNS Drugs
#302
of 1,305 outputs
Outputs of similar age
#11,382
of 91,511 outputs
Outputs of similar age from CNS Drugs
#2
of 15 outputs
Altmetric has tracked 22,774,233 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,305 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.2. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 91,511 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.